Located in Nanjing, the ancient capital of six dynasties on the bank of the Yangtze River, Nanjing Jianbang Jinyuan Technology Co., Ltd. is a wholly-owned mainland subsidiary of Jianbang International Investment Development Group (Hong Kong) Limited. It is a professional service provider focusing on the healthcare industry, integrating R&D, investment and overall solution output.Committed to technological innovation, the company has built a technical, management and marketing service team with high academic qualifications, comprehensive quality and rich practical experience. It has long-term in-depth cooperation with many domestic universities and industry experts and scholars, and serves as a designated internship cooperation base for multiple universities.The company actively participates in grassroots medical construction and public welfare assistance projects, and has gained recognition from project authorities.The company's core products have been clinically applied in many domestic hospitals. Featuring stable performance and outstanding cost advantages, the products have won recognition and trust from customers at home and abroad with reliable quality.Meanwhile, the company distributes high-quality products of affiliated enterprises under the group, including a full range of pathological equipment and pathology department management software from Wuhan Zhongtou Hanjia, as well as in vitro diagnostic reagents from Beijing Beidouxinghang, with complete product categories and comprehensive services.Adhering to the business philosophy of "Innovation, Struggle, Unity and Win-win Cooperation", the company is committed to cooperating with partners from all walks of life for mutual benefit and common development through high-quality product solutions and professional, thoughtful services.

Jiangsu Diyou Pharmaceutical Technology Co., Ltd. is a key domestic member enterprise of Jianbang International Investment Group, serving as the group’s core industrial base focusing on R&D, manufacturing, technology implementation and supporting services for medical devices.The company is mainly engaged in the R&D, production and technical services of in‑vitro diagnostic testing reagents, traditional Chinese medicine moxibustion rehabilitation products, and medical aesthetic skin‑care products.It has built a professional R&D and production team composed of senior engineers, professional engineers and experienced technical staff. The team boasts solid hands‑on experience and competent professional technical capabilities.Committed to scientific research and innovation, the company has obtained more than ten pieces of independent intellectual property rights including patents and software copyrights, and has realized the transformation and application of multiple scientific research achievements.Nanjing Jianbang Jinyuan Medical Technology Co., Ltd., its core holding subsidiary, was founded in December 2016. It has established a standardized production and processing platform for medical devices, disinfection products and cosmetics, equipped with compliant clean workshops, professional warehouses, and complete production and testing equipment.The company continues to deepen industry‑university‑research cooperation with clinical hospitals and institutions of higher learning, and has filed multiple applications for utility model and invention patents.Sound management rules and standardized operation systems have been established. The company has obtained ISO9001, ISO13485 quality management system certifications as well as CE certification, and implements standardized management over production and operation activities.

Shanxi Hanjitang Medical Technology Co., Ltd. is also a key domestic enterprise under Jianbang International Investment Group. It focuses on the R&D, manufacturing and technical services of medical devices, and is mainly engaged in the development and production of in‑vitro diagnostic testing reagents, traditional Chinese medicine moxibustion rehabilitation products, and medical aesthetic skin‑care products.

The enterprise continuously promotes management upgrading and digital transformation. By improving management systems and building a digital management system, it relies on reliable business data, scientific risk assessment and professional financial‑tax analysis to establish an efficient, standardized and refined enterprise operation and management model.In terms of quality control, adhering to the development tenet of "Quality First", the company continuously optimizes product mix and improves production and processing technologies. It has built a quality management system with full‑staff participation and full‑process traceability to steadily improve overall product quality.Driven by innovation, the enterprise has established a standardized full‑process R&D system covering the whole chain of market research, customer demand communication, product trial‑production, testing, implementation follow‑up and iterative optimization. It steadily launches 2‑3 brand‑new products every year. Since 2022, the company has officially entered the light medical beauty skin‑care track, focusing on the R&D of compliant skin‑care products to foster new growth drivers for the enterprise. Meanwhile, it keeps carrying out technical iteration and process optimization for existing products, and consolidates market competitiveness through innovation strength.